左旋肉碱联合重组人红细胞生成素治疗肾性贫血的临床疗效

张立慧

（陕西航天医院，陕西 西安，710025）

浏览次数：113次 下载次数：454次

摘要：

目的 探讨和分析左旋肉碱联合重组人红细胞生成素治疗肾性贫血的临床疗效。方法 选择2016年1月至2017年1月在我院治疗的60例肾性贫血患者作为研究对象，随机分为观察组和对照组，每组30 例。所有患者均进行常规治疗，在血透后 给予重组人红细胞生成素进行治疗，而观察组患者加用左旋肉碱进行治疗，评价两组患者血压升高情况、血红蛋白及红细胞 比容水平。结果 观察组患者血压升高发生率低于对照组患者，差异具有统计学意义（P<0.05）；治疗后，两组患者的血红蛋白 及红细胞比容水平均高于治疗前，且观察组高于对照组（P<0.05）。结论 在肾性贫血患者的治疗中，重组人红细胞生成素同 左旋肉碱联合治疗的效果确切，有效改善了患者的血红蛋白和红细胞比容水平，减少了重组人红细胞生成素的用量，降低血 压升高发生的风险，值得临床应用与推广。

关键词：肾性贫血；左旋肉碱；重组人红细胞生成素

中图分类号：R45文献标志码：A文章编号：2096-1413(2018)06-0050-02

Clinical efficacy of L-carnitine combined with recombinant human erythropoietin in the treatment of renal anemia
ZHANG Li-hui
(Shaanxi Aerospace Hospital, Xi``an 710025, China)

ABSTRACT: Objective To investigate and analyze the clinical efficacy of L-carnitine combined with recombinant human erythropoietin in the treatment of renal anemia. Methods The study selected 60 patients with renal anemia treated in our hospital from January 2016 to January 2017 as subjects. All the patients were randomly divided into observation group and control group, with 30 cases in each group. All patients were treated with conventional treatment, and given recombinant human erythropoietin after hemodialysis. The observation group was treated with L -carnitine on the basis of the conventional treatment. The blood pressure, hemoglobin and hematocrit level in the two groups were evaluated. Results The incidence rate of increased blood pressure in the observation group was lower than that in the control group, the difference was statistically significant (P<0.05). The levels of hemoglobin and hematocrit in the two group were higher than those before treatment, and those of the observation group were higher than the control group (P<0.05). Conclusion In the treatment of patients with renal anemia, the combination of recombinant human erythropoietin and L-carnitine is effective, which can improve the hemoglobin and hematocrit level, reduce the amount of recombinant human erythropoietin and decrease the risk of blood pressure. It is worthy of clinical application and popularization.
KEYWORDS: renal anemia; L-carnitine; recombinant human erythropoietin

参考文献：
[1] DE LIMA GA,MAZZALI M,GENTIL AF,et al.Anemia in chronic renal disease: evaluation of inflammatory activity on erythropoiesis and iron metabolism in patients not submitted to dialysis treatment[J].Clin Lab,2012,58(7-8):695-704.
[2] 郭燕,李卫华,李国刚,等.腹膜透析患者不同频率使用重组人红细 胞生成素治疗肾性贫血[J].中国临床医生杂志,2015,34(10):31-33.
[3] 陈娟娟,邢小红,张晓萍,等.大剂量静脉补铁联合促红细胞生成素 纠正腹膜透析患者肾性贫血的效果观察及护理[J].齐鲁护理杂志,2015,28(10):31-33.
[4] 李萍.补气化瘀方配合重组人红细胞生成素治疗肾性贫血46 例[J].河南中医,2014,34(8):1559-1560.
[5] 沈永侠.不同给药途径应用重组人红细胞生成素治疗血液透析患者肾性贫血的疗效与安全性[J].医药前沿,2015,5(31):107-108.
[6] 张虹,苏小勇.重组人红细胞生成素对治疗肾性贫血的临床观察[J].中国社区医师:医学专业,2012,14(7):98.
[7] 沈永侠.不同给药途径应用重组人红细胞生成素治疗血液透析患者肾性贫血的疗效与安全性[J].医药前沿,2015,5(31):107-108.
[8] 刘玉平,李金环,张秀娟,等.促红细胞生成素联合左旋肉碱对肾性贫血患者内皮素及左室重构临床研究[J].中国医药导报,2012,9(5):31-32.
[9] 邝红漫.肾性贫血治疗及进展[J].医药前沿,2014,35(20):379-380.
[10] 吴爱红,尼二超.左旋肉碱联合重组人红细胞生成素治疗肾性贫 血的临床研究[J].中国医药导报,2012,9(18):191-192.
[11] 马欣.左旋肉碱联合重组人红细胞生成素治疗肾性贫血的临床研 究[J].中国保健营养,2013,23(6):3262.